title: The stimulation of PD-L1-specific cytotoxic T lymphocytes can both directly and indirectly enhance antileukemic immunity.
authors.affiliation: Center for Cancer Immune Therapy (CCIT), Department of Hematology and Oncology, Copenhagen University Hospital, Herlev, Herlev, Denmark.
authors.forename: S M
authors.initials: SM
authors.lastname: Ahmad
authors.affiliation: Center for Cancer Immune Therapy (CCIT), Department of Hematology and Oncology, Copenhagen University Hospital, Herlev, Herlev, Denmark.
authors.forename: I M
authors.initials: IM
authors.lastname: Svane
authors.affiliation: Center for Cancer Immune Therapy (CCIT), Department of Hematology and Oncology, Copenhagen University Hospital, Herlev, Herlev, Denmark.
authors.forename: M H
authors.initials: MH
authors.lastname: Andersen
mesh_terms: D060890:B7-H1 Antigen / Q000037:antagonists & inhibitors / Q000276:immunology*; D019496:Cancer Vaccines / Q000276:immunology / Q000494:pharmacology; D018984:Epitopes, T-Lymphocyte / Q000276:immunology; D006801:Humans; D007114:Immunization; D007938:Leukemia / Q000276:immunology* / Q000628:therapy*; D010455:Peptides / Q000276:immunology / Q000494:pharmacology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
chemical_list: D060890:B7-H1 Antigen; C423236:CD274 protein, human; D019496:Cancer Vaccines; D018984:Epitopes, T-Lymphocyte; D010455:Peptides